Introduction
Novomix is a prescription medication that contains the active ingredients Insulin Aspart and Insulin Aspart Protamine. It is available in the form of a suspension.
Uses
Novomix is primarily used to help control blood sugar levels in individuals with diabetes. It is indicated for the management of both type 1 and type 2 diabetes. This medication helps to regulate blood sugar levels by mimicking the actions of natural insulin, a hormone produced by the pancreas.
Dosage and Administration
The dosage of Novomix will vary depending on individual patient factors and should be determined by a healthcare professional. It is typically administered by injection under the skin, known as subcutaneous injection. The injection site should be rotated to avoid lipodystrophy.
Mechanism of Action
Insulin Aspart and Insulin Aspart Protamine in Novomix work together to regulate blood sugar levels. Insulin Aspart acts rapidly to lower blood sugar levels after meals, while Insulin Aspart Protamine has a prolonged action, providing a more stable control of blood sugar levels throughout the day.
Side Effects
Common side effects of Novomix may include injection site reactions such as redness, swelling, or itching. Other common side effects may include hypoglycemia (low blood sugar), weight gain, and hypokalemia (low potassium levels). If any of these side effects occur, consult a healthcare professional.
Serious side effects of Novomix may include severe hypoglycemia, allergic reactions, and injection site infections. If any serious side effects occur, immediate medical attention should be sought.
Drug Interactions
Novomix may interact with certain medications, including oral antidiabetic drugs, beta-blockers, and corticosteroids. Inform your healthcare professional about all medications you are taking, including prescription, over-the-counter, and herbal products, to avoid potential interactions.
Precautions
Before using Novomix, inform your healthcare professional about any medical conditions you have, especially kidney or liver problems, as well as any allergies you may have.
This medication should not be used during episodes of hypoglycemia or if you are allergic to any of its ingredients. Monitor blood sugar levels regularly while using Novomix.
Storage
Novomix should be stored in a refrigerator at a temperature between 2°C and 8°C (36°F and 46°F). Do not freeze the medication. Keep it away from direct sunlight and protect it from excessive heat.
Patient Tips
- Follow the dosage instructions provided by your healthcare professional.
- Learn how to properly administer the medication through subcutaneous injection.
- Keep track of your blood sugar levels and report any significant changes to your healthcare professional.
- Be aware of the signs and symptoms of hypoglycemia and seek immediate medical attention if they occur.
- Store the medication properly in the refrigerator, and check its expiration date before use.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Type 1 diabetes – Managing insulin (NHS UK) [Accessed 14 Jun. 2024] (online) Available at:
- Fiasp 100 units/mL FlexTouch solution for injection in pre-filled pen (Health Professionals SmPC) Available at:
- Insulin aspart protamine Interactions (Drugs.com) [Accessed 16 Jun. 2024] (online) Available at:
- insulin aspar prt-insulin aspart 100 unit/ml (70-30) subcutaneous soln intermediate-, long-acting, and combination insulins (RX) [Accessed 13 Jun. 2024] (online) Available at:
- Insulin (Food and Drug Administration) [Accessed 26 Jun. 2024] (online) Available at:
- Rosenstock J, Emral R, Sauque-Reyna L, Mohan V, Trescolí C, Al Sifri S, Lalic N, Alvarez A, Picard P, Bonnemaire M, Demil N, McCrimmon RJ; SoliMix Trial Investigators. Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial. Diabetes Care. 2021 Jun 28;44(10):2361-70. doi: 10.2337/dc21-0393. Online ahead of print. [Accessed 30 Jun. 2024] Available at:
Reviews
There are no reviews yet.